Healionics - News

Seattle, WA (August 29, 2018) — Healionics Corporation, a Seattle-based medical device company, has announced the addition of Ryan Takeuchi to its board of directors...

May 20, 2018

Healionics’ spinout company, iSTAR Medical, announces First-In-Human results of its “MINIject” for treating glaucoma

Healionics’ spinout company, iSTAR Medical, just announced exciting First-In-Human 6-month results of its “MINIject” for treating...

November 16, 2017

Healionics Awarded $1.7M SBIR Grant from NIH to Advance New Vascular Graft Toward First-In-Human Use

Healionics Press Release – 171116 – SBIR Clinical Fast-Track

November 17, 2016

Healionics’ Vascular Access Device Featured at the American Society of Nephrology’s Kidney Week 2016

April 22, 2016

Healionics’ Adrienne Oda in Forbes magazine’s “30 Under 30“

March 17, 2016

Healionics Announces the Appointment of Mike Connolly as Chief Executive Officer

December 1, 2015

Healionics Awarded $1.5M SBIR Grant from NIH to Advance Clot-Resistant Synthetic Vascular Graft for Dialysis Patients

July 1, 2015

Healionics’ Adrienne Oda recognized in Manufacturing Engineering

April 22, 2015

Healionics Awarded $1.3 Million Phase II NIH SBIR Grant to Advance Development of a Next-Generation Hemodialysis Access Device

December 17, 2014

Healionics Awarded SBIR Contract from DOD to Develop Biointegrated Synthetic Vascular Graft

September 8, 2014

Healionics Receives SBIR Grant from National Institutes of Health to Develop Needle Free Dialysis Access Devices

February 13, 2014

Second Patent Issued for Healionics’ Textured STAR Biointerface

August 29, 2013

Healionics’ Buddy Ratner Receives European Society for Biomaterials Award

August 22, 2013

Healionics Receives ISO 13485 Certification

March 9, 2013

Healionics Featured in The Economist

February 12, 2013

Patent Issued for Healionics’ Textured STAR® Biointerface

November 15, 2012

Patent Expands Coverage for Healionics’ STAR® Biomaterial Technology

September 20, 2012

Healionics Awarded $900k Grant from NIH

August 20, 2012

Healionics’ Andrew Marshall to be Awarded the Innovation / Commercialization Award at the TERMIS World Congress

July 3, 2012

iSTAR Medical Receives CE Mark Approval for STARflo Glaucoma Implant

June 5, 2012

Healionics’ Andrew Marshall named one of 40 Under 40 by MD+DI

April 16, 2012

University of Washington and Healionics Team Up to Win Life Sciences Discovery Fund (LSDF) Award

July 5, 2011

Patent Issued for Healionics’ STAR Biomaterial

April 8, 2011

Dr. Andrew Marshall to Speak on STAR’s Ability to Combat Catheter-Related Infection at the Society for Biomaterials in Orlando, Florida

November 12, 2010

Healionics Receives $244,500 Grant from the QTDP Program

October 26, 2010

Healionics Launches iSTAR Medical with Belgian Financial Support Spinout to develop “next generation” ophthalmic implants with STAR Biomaterial

October 6, 2010

Healionics to Present at AdvaMed 2010

August 9, 2010

STAR Technology Helps University of Washington Researchers Repair Damaged Hearts

July 30, 2010

Healionics Receives $200,000 Award from National Institutes of Health

July 15, 2010

Healionics Partners with UW, Receives Washington Technology Center (WTC) Award for Infection-Reducing Biotechnology

July 8, 2010

University of Washington Receives Research and Development (RTD) Award with Healionics as Company Partner

March 25, 2010

Healionics to Present at the Translational Regenerative Medicine Venture Forum

February 2, 2010

Dr. Andrew Marshall to Speak on STAR’s Ophthalmic Applications at the Society for Biomaterials in Seattle

November 30, 2009

Dr. Buddy Ratner Presents Research on Healing and Regeneration at the Material Research Society’s Fall Meeting

October 9, 2009

Healionics Receives STTR Grant from National Institutes of Health (NIH) to Develop New Artificial Cornea

September 30, 2009

Healionics Selected to Present at AdvaMed 2009

September 11, 2009

Dr. Buddy Ratner Receives Prestigious 2009 Acta Biomaterialia Gold Medal Award

September 2, 2009

Healionics Named as Collaborating Organization in the Life Sciences Discovery Fund (LSDF) Award for Catheter Research

June 26, 2009

Dr. Andrew Marshall to Present STAR® Biomaterial at World Congress of Tissue Engineering and Regenerative Medicine International Society (TERMIS)

June 15, 2009

Dr. Andrew Marshall Presents STAR® Biomaterial Scaffolds for Wound Repair and Device Biointegration at Polymers in Medicine and Biology: 2009

April 23, 2009

MassDevice features Healionics

March 25, 2009

Healionics Takes First Step Toward Glaucoma Treatment, Appoints New CEO

March 25, 2009

Healionics helps introduce glaucoma implant for dogs

March 24, 2009

Healionics Ships First Commercial Product Featuring STAR Biomaterial

March 18, 2009

Healionics to Present Research on STARcuff™ at Society For Biomaterials Annual Meeting

December 11, 2008

Healionics Completes Series B Financing

September 9, 2008

Healionics Signs Deal To Make Components for Glaucoma Device in Dogs

August 12, 2008

Healionics Gets Kudos in Congress

June 5, 2008

Healionics Expands Research Applications for STAR® Biomaterial Scaffold

March 17, 2008

Healionics CEO Rob Brown interviewed by The Wall Street Transcript

March 1, 2008

Healionics CEO Rob Brown featured in Entrepreneur magazine

January 29, 2008

Healionics completes Series A Financing

December 18, 2007

Healionics signs agreements to advance STAR research in implanted glucose sensor and negative pressure wound therapy applications.

December 1, 2007

Healionics named “Most Promising New BioTech Firm” by Seattle Business Monthly, December 2007

September 12, 2007

Healionics awarded Best Technology Investment at 2007 ZINO Zillionaire Investment Forum

News

MEDIA INQUIRIES